Oral Answers to Questions Debate
Full Debate: Read Full DebateDepartment: Foreign, Commonwealth & Development Office
Sarah Champion
Main Page: Sarah Champion (Labour - Rotherham)Department Debates - View all Sarah Champion's debates with the Foreign, Commonwealth & Development Office
(3 years, 3 months ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Wendy Morton
I do not accept the hon. Lady’s assertions when it comes to transparency. We, the UK, are absolutely at the forefront of multilateral efforts on ensuring equitable global access. If we look at what the UK Government have done, we see that we have contributed to CEPI—the Coalition for Epidemic Preparedness Innovations—in the early part of this pandemic and to FIND, the Foundation for Innovative New Diagnostics. We have contributed to Gavi and to the COVAX AMC. This is all about helping the world’s poorest. We have also flexed a lot of our normal aid work to help countries that are suffering from the pandemic, because we know that, as well as the primary impact of covid-19, there are many secondary impacts.
Sarah Champion (Rotherham) (Lab) [V]
The Minister is right that vaccines alone are not enough, and she is aware that the International Development Committee has just done an inquiry on the secondary impacts, which show that developing countries are suffering economically through their healthcare and through gender inequality. What efforts and preparations are being made by FCDO to prevent there being a development mountain to climb after the pandemic subsides?
Wendy Morton
I recognise the work of the IDC and I am very pleased that its work is continuing. Let me just reiterate that when it comes to covid-19, the UK and the FCDO remain at the forefront. With the funds that we have, we continue to support the world’s poorest, and we will continue to focus on the bottom billion. Yes, it is about working with the development world, but it is also about working, where we can, with the public sector and the private sector. I look to the example of Oxford-AstraZeneca. The UK Government invested £84 million in helping to develop that vaccine, and we are now rolling it out. We have committed to the AMC, and we are absolutely committed to helping the world’s poorest.[Official Report, 25 January 2021, Vol. 688, c. 2MC.]